CA Stock MarketDetailed Quotes
CTX Crescita Therapeutics Inc
- 0.510
- 0.0000.00%
15min DelayMarket Closed Jul 4 16:00 ET
9.91MMarket Cap-4250P/E (TTM)
0.000High0.000Low0Volume0.000Open0.510Pre Close0.00Turnover0.73052wk High0.00%Turnover Ratio19.44MShares0.36052wk Low-0.12EPS TTM8.70MFloat Cap2.000Historical HighLossP/E (Static)17.06MShs Float0.350Historical Low-0.1EPS LYR0.00%Amplitude--Dividend TTM0.55P/B1Lot Size--Div YieldTTM
Crescita Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.56%5M | -25.52%17.52M | -21.64%4.73M | -49.72%3.03M | -20.73%5.16M | -7.05%4.6M | 40.29%23.53M | -20.26%6.03M | 101.54%6.03M | 120.82%6.51M |
| Operating revenue | 8.56%5M | -25.52%17.52M | -21.64%4.73M | -49.72%3.03M | -20.73%5.16M | -7.05%4.6M | 40.29%23.53M | -20.26%6.03M | 101.54%6.03M | 120.82%6.51M |
| Cost of revenue | 38.53%2.59M | -30.79%7.16M | -22.38%1.67M | -50.42%1.53M | -26.95%2.09M | -16.66%1.87M | 53.12%10.34M | -26.31%2.15M | 110.76%3.09M | 133.50%2.87M |
| Gross profit | -11.88%2.41M | -21.38%10.36M | -21.24%3.06M | -48.98%1.5M | -15.85%3.07M | 0.88%2.74M | 31.64%13.18M | -16.47%3.89M | 92.66%2.94M | 111.79%3.65M |
| Operating expense | 5.72%3.14M | -2.63%12.32M | -4.23%3.17M | 2.67%2.88M | -4.41%3.3M | -3.76%2.97M | 17.89%12.65M | -6.31%3.31M | 17.61%2.81M | 43.68%3.45M |
| Selling and administrative expenses | 6.73%2.35M | -4.33%10.12M | -7.20%2.58M | 3.24%2.36M | -5.97%2.74M | -6.75%2.2M | 21.25%10.57M | -8.02%2.78M | 19.75%2.29M | 51.09%2.92M |
| -General and administrative expense | 6.73%2.35M | ---- | ---- | ---- | ---- | -6.75%2.2M | ---- | ---- | ---- | ---- |
| Research and development costs | 6.25%170K | 14.78%699K | 36.25%218K | -11.18%143K | 10.56%178K | 25.98%160K | -3.94%609K | -6.43%160K | 27.78%161K | 36.44%161K |
| Depreciation amortization depletion | 1.95%626K | 2.38%1.51M | 0.53%379K | 5.31%377K | 1.35%375K | 1.66%614K | 6.67%1.47M | 8.65%377K | 2.29%358K | 5.41%370K |
| -Depreciation and amortization | 1.95%626K | 2.38%1.51M | 0.53%379K | 5.31%377K | 1.35%375K | 1.66%614K | 6.67%1.47M | 8.65%377K | 2.29%358K | 5.41%370K |
| Operating profit | -209.75%-731K | -469.75%-1.96M | -119.76%-113K | -1,138.35%-1.38M | -213.00%-226K | 37.23%-236K | 173.57%529K | -48.70%572K | 115.47%133K | 129.54%200K |
| Net non-operating interest income (expenses) | 18.37%116K | 313.73%422K | 101.47%137K | 64.29%92K | 1,457.14%95K | 753.33%98K | 288.89%102K | 585.71%68K | 307.41%56K | 72.00%-7K |
| Non-operating interest income | 10.74%134K | 95.00%507K | 70.65%157K | 39.51%113K | 182.93%116K | 163.04%121K | 42.86%260K | 91.67%92K | 125.00%81K | 7.89%41K |
| Non-operating interest expense | -21.74%18K | -46.20%85K | -16.67%20K | -16.00%21K | -56.25%21K | -62.30%23K | -33.05%158K | -61.29%24K | -60.32%25K | -23.81%48K |
| Other net income (expenses) | -135.48%-11K | 101.76%4K | -71.25%23K | 16.67%7K | 75.22%-57K | 137.35%31K | 3.81%-227K | 229.03%80K | 146.15%6K | -2,200.00%-230K |
| Gain on sale of security | -108.70%-2K | 92.94%-12K | -69.16%33K | -128.57%-2K | 69.01%-66K | 132.39%23K | 30.33%-170K | 252.86%107K | 153.85%7K | -2,030.00%-213K |
| Income before tax | -485.05%-626K | -478.71%-1.53M | -93.47%47K | -757.44%-1.28M | -408.11%-188K | 77.43%-107K | 140.04%404K | -30.70%720K | 121.67%195K | 94.80%-37K |
| Income tax | 0 | 199.56%456K | 143.01%197K | 0 | 166K | -577.08%-458K | -458K | 0 | ||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -129.30%-626K | -330.39%-1.99M | -112.73%-150K | -757.44%-1.28M | -659.46%-281K | 42.41%-273K | 178.01%862K | 24.92%1.18M | 121.67%195K | 94.80%-37K |
| Net income continuous operations | -129.30%-626K | -330.39%-1.99M | -112.73%-150K | -757.44%-1.28M | -408.11%-188K | 42.41%-273K | 178.01%862K | 24.92%1.18M | 121.67%195K | 94.80%-37K |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---93K | ---- | ---- | ---- | ---- | --0 |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -129.30%-626K | -330.39%-1.99M | -112.73%-150K | -757.44%-1.28M | -659.46%-281K | 42.41%-273K | 178.01%862K | 24.92%1.18M | 121.67%195K | 94.80%-37K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -129.30%-626K | -330.39%-1.99M | -112.73%-150K | -757.44%-1.28M | -659.46%-281K | 42.41%-273K | 178.01%862K | 24.92%1.18M | 121.67%195K | 94.80%-37K |
| Diluted earnings per share | -200.00%-0.03 | -350.00%-0.1 | -116.67%-0.01 | -700.00%-0.06 | -462.43%-0.01 | 50.00%-0.01 | 180.00%0.04 | 20.00%0.06 | 125.00%0.01 | 94.07%-0.0018 |
| Basic earnings per share | -200.00%-0.03 | -350.00%-0.1 | -116.67%-0.01 | -700.00%-0.06 | -462.43%-0.01 | 50.00%-0.01 | 180.00%0.04 | 20.00%0.06 | 125.00%0.01 | 94.07%-0.0018 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg